Mitochondrial dysfunction is a key feature of cancer and is frequently associated with increased aggressiveness and metastatic potential. Recent evidence has brought to light a metabolic rewiring that takes place during the epithelial-to-mesenchymal transition (EMT), a process that drives the invasive capability of malignant tumors, and highlights a mechanistic link between mitochondrial dysfunction and EMT that has been only partially investigated. In this study, we characterized mitochondrial function and bioenergetic status of cultured human breast cancer cell lines, including luminal-like and basal-like subtypes. Through a combination of biochemical and functional studies, we demonstrated that basal-like cell lines exhibit impaired, but not completely inactive, mitochondrial function, and rely on a consequent metabolic switch to glycolysis to support their ATP demand. These altered metabolic activities are linked to modifications of key electron transport chain proteins and a significant increase in levels of reactive oxygen species compared to luminal cells. Furthermore, we observed that the stable knockdown of EMT markers caused functional changes in mitochondria that result in acquisition of a hybrid glycolysis/OXPHOS phenotype in cancer cells as a means to sustain their metabolic demand.
Introduction
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therapy and other central cellular processes of tumorigenesis, suggesting that metabolic alterations seem to be absolutely required for malignant transformation [2] . One of the most frequently recognized and wellcharacterized metabolic phenotype observed in tumor cells is the Warburg effect, which is described as an increase in the rate of glycolysis, even under normal oxygen concentrations, associated with diminished mitochondrial function. Thus, unlike most normal cells, cancer cells generate ATP from aerobic glycolysis, converting most incoming glucose to lactate rather than metabolizing it in mitochondria through oxidative phosphorylation (OXPHOS) [1] . The causes and mechanisms of glycolytic switch leading to metabolic reprogramming are still under debate [3] . Initially, it was thought that altered metabolism arose from mitochondrial defects that inhibited their ability to effectively oxidize glucose carbon to CO 2 , thus forcing tumor cells to adapt their metabolism and compensate for the respiratory deficiency [4] . However, more recent evidence indicates that tumor mitochondria are not defective in their ability to carry out OXPHOS but can retain full oxidative capacities, suggesting that dysfunctional mitochondrial metabolism may not be completely responsible for aerobic glycolysis [5] [6] [7] . According to this hypothesis, metabolic reprogramming is the result of activation of specific signaling pathways and transcriptional networks that support cancer cells proliferation and survival in response to stressful and dynamic microenvironmental conditions such as hypoxia, or to nutrient limitation [8] . Indeed, a high glycolytic rate provides growth advantages for tumor cells, such as faster synthesis of ATP compared to mitochondrial OXPHOS, synthesis of ATP independently of oxygen, prevention of excessive reactive oxygen species (ROS) production, and support of active cell proliferation by providing carbon sources that can be used for nucleotide, lipid, and amino acid synthesis [3, 9] .
In line with the role of metabolism in cancer biology, increasing evidence associates a specific metabolic reprogramming with the induction and maintenance of the epithelial-to-mesenchymal transition (EMT) program [10, 11] . During EMT, epithelial cancer cells lose their epithelial features and acquire a mesenchymal phenotype, thus promoting motility and invasion. The process proceeds through the loss of cell polarity and disruption of cell-cell junctions including the E-cadherin/b-catenin complex that plays an important role for the establishment of functional anchoring junctions and, consequently, for maintaining epithelial integrity. Other than their structural role in stabilizing cell-cell contact, components of cadherin-catenin complex serve a role in activating several key signal transduction networks. For these reasons, loss of E-cadherin or b-catenin expression is a crucial step of EMT and is involved in cancer invasion and metastasis. This is obtained by the activation of a complex network of transcriptional factors that repress the expression of epithelial genes and modify profoundly the phenotype of tumor cells including metabolic networks that can contribute to the metastatic transformation [11] . However, the link between EMT and metabolic reprogramming in cancer is still subject to debate. Recent findings indicate that mesenchymal cancer cells have different metabolic needs, compared with their epithelial counterparts, to satisfy the metabolic demands of increased motility and invasion, suggesting that EMT activation induces metabolic rewiring. On the other hand, in some circumstances, dysregulation of metabolic pathways is associated with EMT induction [11] . Thus, the theory of a mutual interplay between EMT and metabolism is increasingly taking hold.
Mitochondrial defects have a role in cancer and consequently can affect EMT. Impaired OXPHOS, a consequence of mitochondrial dysfunction, has been shown to be involved in tumorigenesis. Indeed, mitochondrial alterations are essential for the metabolic rewiring that characterizes certain cancer cells during cancer progression [12] .
The observed alteration of mitochondrial functionality has been associated with the worst clinical outcome across multiple cancer types and correlated with a specific EMT gene signature. In fact, given the role of EMT in cancer metastasis [13] , a link has been hypothesized between the regulation of mitochondrial genes, induction of EMT, and the metastatic potential of cancer, which is directly related to patient prognosis [14] . Recent scientific literature provides contradictory results concerning the metabolic phenotype of invasive EMTcommitted cancer cells, as glycolytic or OXPHOS dependent in various tumor types as well as within individual cancer types. Indeed, recent studies have reported that overloading of respiratory mitochondrial metabolism is often associated with EMT and with the acquisition of proinvasive activity of cancer cells [15] , whereas other data revealed that the inhibition of the downregulation of OXPHOS-related genes correlates with metastatic potential of cancer, which is directly linked to a poor clinical outcome, and is associated with EMT [14] . Accumulating evidences suggest that EMT is one of the main mechanisms involved in breast cancer progression and metastasis [16, 17] . Although significant progress has been made in understanding cellular and molecular changes occurring during EMT, very little is known about EMT-induced metabolic changes in breast cancer.
In this study, we report a detailed biochemical and functional characterization of the main aspects of energy metabolism in breast cancer cell line models, focusing particularly on mitochondrial dysfunction and impairment leading to cancer transformation and progression. To determine EMT-induced metabolic reprogramming, we used human breast adenocarcinoma cell lines, which are known to be considerably different both clinically and pathologically: MCF-7, T47D [luminal-like breast cell lines, estrogen (ER) and progesterone (PGR) receptor positive, and weakly invasive in vitro], MDA-MB-231, and MDA-MB-435 (mesenchymal-like breast cell lines, ER and PGR receptor negative, and highly invasive in vitro) [18] [19] [20] . Moreover, we investigated the possible metabolic alterations induced by the stable knockdown of E-cadherin or b-catenin in the breast cancer cell line MCF-7.
The results provide an opportunity to better understand the bioenergetic differences between epithelial and mesenchymal cell types, and clarify their different involvement in the acquisition of metastatic properties. Such knowledge could be useful in the development of novel diagnostic and therapeutic interventions for tumor metastasis.
Results

Mitochondrial OXPHOS defects in breast cancer cells
To examine the existence of a metabolic phenotype associated with tumor metastasis, we used two models of breast carcinoma cells with different metastatic potentials, MCF-7 and MDA-MB-231 [21] .
Initially, we evaluated the mitochondrial respiratory efficiency of two breast cancer cell lines by measuring their oxygen consumption using the oxygraphic method and the enzymatic activity of single respiratory complexes by means of spectrophotometric methods.
Mitochondrial oxygen consumption, expressed as nmol O 2 Ámin À1 9 10 À6 cells, was measured by adding various respiratory substrates for mitochondrial complexes I, II, and IV in the presence (respiration state 3, also known as V 3 ) or in the absence (respiration state 4, also known as V 4 ) of ADP ( Table 1 ). The respiratory control ratio (RCR) was calculated by dividing V 3 by V 4 .
In the presence of pyruvate and malate, metabolic substrates for complex I, V 3 , and V 4 values were lower in MDA-MB-231 cells (75% and 63%, respectively) in comparison to MCF-7 cells. When mitochondrial respiration was activated by the inhibition of complex I (through the addition of rotenone) and the addition of respiratory substrates for complex II (succinate), a lower V 3 value (reduced by approximately 50%) was measured in MDA-MB-231 cells, whereas V 4 did not show evident differences between the two tested cancer cell lines. No significant difference in V 3 values was observed after the inhibition of complexes I, II, and III (by the addition of rotenone, malonate, and antimycin A, respectively) and the addition of respiratory substrates for complex IV (TMPD and ascorbate). In MCF-7 cells, V 4 value was lower by about 45% than in MDA-MB-231 cells. Consequently, the respiratory control ratio (RCR) values calculated by dividing V 3 by V 4 were significantly lower in the basal-type cell line compared to those calculated for the luminal-type cell line. The RCR is a direct measure of mitochondrial respiratory efficiency [22, 23] and the values found in both cell lines suggest a partial uncoupling between respiration and phosphorylation in mitochondria, which was particularly marked for the MDA-MB-231 cell line compared to MCF-7 cells. Figure 1A shows similar experiments in which oxygen uptake by cells was measured polarographically in To investigate the functionality of mitochondrial OXPHOS, we assayed the activity of single components of the respiratory chain by means of spectrophotometric analysis (Fig. 1B) . Also in this case, we found a lower enzymatic activity for complex I (~60%) in MDA-MB-231 cells compared to MCF-7 cells. On the contrary, the activity of complex IV was almost sixfold higher in MDA-MB-231 cells than in MCF-7 cells. No significant change was observed in the activity of mitochondrial complexes II and III.
All experiments aimed toward the characterization of mitochondrial function were carried out also on freshly intact mitochondria isolated from breast cancer cells and similar results to those performed on cell lysates were obtained (data not shown).
To test if the decrease in mitochondrial oxidative activity observed in MDA-MB-231 cells might be correlated with a compromised mitochondria biogenesis, the mitochondrial mass of the two breast cancer cell lines was evaluated by analyzing mtDNA copy number relative to nDNA copy number by real-time PCR. The results reported in Fig. 2A show a markedly higher relative mtDNA content in MDA-MB-231 cells than in MCF-7 cells, suggesting a compensatory response to the impaired respiratory function. Moreover, the expression of transcriptional regulators of mitochondrial function and biogenesis in mammalian cells [24] was investigated. Real-time PCR revealed a higher expression level of mitochondrial transcription factor A (TFAM) in MDA-MB-231 cells compared to MCF-7 cells (Fig. 2B) . Thus, MDA-MB-231 cells showed an increase in mtDNA content that is correlated with an upregulation of TFAM, essentially involved in mitochondrial transcription machinery and in the regulation of mtDNA copy number. On the other hand, the expression of peroxisome proliferator-activated receptor coactivator-1a (PGC-1a) and nuclear respiratory factor1 (NRF1) did not show significant differences between the two cell lines (Fig. 2B) . The mitochondrial transmembrane potential (DΨ m ) was also evaluated; it was higher in basal-like cells as indicated by a higher ratio of JC-1 red to green fluorescence (Fig. 2C) , suggesting that the integrity of the mitochondrial inner membrane was maintained. In consideration of these results, we hypothesized that specific defects of OXPHOS protein subunits might account for the observed functional defects. To test this, we determined OXPHOS protein expression levels by western blotting (Fig. 3A,B) . In MDA-MB-231 cells, protein analysis revealed a reduction in the expression of complex I NDUFB8 and complex II SDHB subunits, whereas no differences in the protein levels of complex I NDUFS1 and NDUFV1 catalytic subunits, and complex II SDHA were observed. Moreover, there were no significant changes in the expression of complex III subunit UQCRC2 and in complex IV subunit COX1. Differences in the protein levels appeared more evident for complex V or ATP synthase, which is associated with its substrate suppliers, ADP/ATP translocase (ANT) and inorganic phosphate carrier (PiC), to form a single catalytic unit responsible for ATP production, known as ATP synthasome [25] . Western blotting analysis showed a higher expression level of the main catalytic subunits of complex V (ATP5A, ATP5B, and ATP5C) and of its natural inhibitor protein, ATPase inhibitory factor 1 (ATPIF1), in MCF-7 compared to MDA-MB-231 cells. Interestingly, all the three adenine nucleotide translocator (ANT1 to ANT3) isoforms were differentially expressed in the two breast cancer cell lines. In particular, ANT1 was found upregulated in MDA-MB-231 cells, whereas ANT2 and ANT3 were more highly expressed in MCF-7 cells. On the other hand, no significant differences were observed in PiC expression. To correlate the variation in ANT protein expression to changes at the mRNA level, we validated western blotting data by real-time PCR analysis. When the transcript levels were normalized to that of Rplp0 selected as the reference gene, the mRNA level of ANT1 in MDA-MB-231 cells was about threefold greater than in MCF-7 cells, whereas the expression of ANT2 and ANT3 was twofold higher in MCF-7 cells relative to MDA-MB-231 (Fig. 3C) . Moreover, the higher levels of the main ATP synthase catalytic subunits (ATP5A, ATP5B, and ATP5C) and its regulator (ATPIF1) in MCF-7 cells compared to the MDA-MB-231 cell line were confirmed as well.
Impaired mitochondrial function and redox homeostasis
It is well established that mitochondria are the primary source of ROS, and that impairments of the respiratory chain and mitochondrial function result in ROS production [26] . To assess whether alterations in the generation of ROS also occur in association with the mitochondrial metabolic function of the breast cancer cell models, we measured intracellular and extracellular ROS levels in the two cell lineages over a time period of 120 min. Regarding intracellular ROS levels, both cancer cell lines maintained a constant cellular level of H 2 O 2 at different defined times which was significantly higher in MDA-MB-231 compared to MCF-7 cells (starting from Data were normalized to Rplp0 mRNA levels and are presented as mean of relative fold change AE SD from four independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001 vs MCF-7 cells, using Student's t-test).
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The FEBS Journal 286 (2019) 688-709 ª 2019 Federation of European Biochemical Societies 60 min) (Fig. 4A) . Moreover, we observed that the two cell lines produced increasing amounts of extracellular hydrogen peroxide over time, with MDA-MB-231 cells generating the higher levels (Fig. 4B ).
Because it is widely known that abnormal levels of ROS induce oxidative stress leading to damage of the terrabiological macromolecules, we detected and quantified protein carbonylation and lipid peroxidation levels. This is considered to be a key biomarker of oxidative damage because proteins and lipids are the major target for oxidants. Metal-catalyzed oxidation of proteins introduces carbonyl groups (aldehydes and ketones) at proline, arginine, threonine, or lysine residues in a site-specific manner [27] . Lipid peroxidation results in the formation of highly reactive and unstable hydroperoxides of both saturated and unsaturated lipids. We determined post-translational modification of cellular proteins by OxyBlot analysis and measured lipid peroxidation by using the PeroxiDetect Maintaining the ROS level in a balanced state and the proper functioning of redox systems are crucial for redox status in living cells. Redox balance is based on the generation and elimination of ROS by endogenous cellular defense mechanisms, including enzyme systems involved in free radical scavenging. Hence to further investigate redox homeostasis, we evaluated the activity of intracellular antioxidant enzymes such as peroxidases, catalase, and SOD. Total peroxidase activity did not differ among cells, while catalase activity was significantly higher in MDA-MB-231 cells than in MCF-7 cells (Fig. 4E ). On the other hand, total SOD activity (cytosolic and mitochondrial) did not reveal a significant difference between the two cell lines, but mitochondrial SOD (SOD2) activity was almost three times higher in MDA-MB-231 cells than in MCF-7 cells (Fig. 4E) .
The high activity of SOD2 in basal-like breast carcinoma cells led us to further investigate the potential in vitro role of this antioxidant enzyme in EMT. For this reason, we analyzed public RNA-sequencing and microarray data sets to investigate the expression profile of SOD isoforms in luminal and basal subtypes of breast cancer cells. First, a GEO RNA-sequencing data set (GSE100878) [28] showed that SOD1 mRNA levels were only slightly different between the two lineages, whereas SOD2 mRNA levels were about twofold higher in MDA-MB-231 cells than in MCF-7 cells (Fig. 5A ). SOD3 (extracellular SOD isoform) mRNA levels were significantly higher in MDA-MB-231 cells compared to MCF-7 cells, where they were almost undetectable (Fig. 5A) . Moreover, analysis of the GEO microarray data set (GSE41313) [29] in 48 breast cancer cell lines (18 luminal-like and 20 basal-like subtypes) revealed a significantly higher expression of the SOD2 isoform in basal-like types, compared with luminal ones (Fig. 5B) . On the contrary, SOD1 and SOD3 isoform expression did not differ between the cell lineages (Fig. 5B) . Finally, analysis of the ONCO-MINE microarray platform indicated that SOD2 is significantly upregulated in tumor samples of basal-like breast cancers subtypes (Fig. 5C ). This evidence was confirmed by the analysis of the Breast cancer Online database (GOBO) performed in multiple subgroups of 1881-sample breast cancer data set. Figure 5D shows that SOD2 expression levels differed between the breast cancer subtypes: basal subtype had the highest expression of SOD2, while the lowest was in the luminal-like subtype. Moreover, SOD2 expression levels were associated with tumor grade and malignancy being highest at histological grade III (Fig. 5E ).
Bioenergetic function of MCF-7 and MDA-MB-231 cell lines
Based on the observation that MCF-7 and MDA-MB-231 cell lines exhibited differently impaired mitochondrial function, we investigated the relative contribution of glycolytic metabolism by measuring lactate production as an indicator of glycolysis rate.
Cells were seeded onto plates and allowed to grow in complete medium for attachment overnight. The next day, we replaced the complete medium with fresh medium at time zero. From time zero, every 2 h, we collected media and cells in the same plate. The concentrations of lactate in medium and cellular samples were measured using a colorimetric assay. We found that intracellular lactate levels remained relatively constant over time (from 2 to 10 h) and were significantly higher, about twofold, in MDA-MB-231 cells compared to MCF-7 cells (Fig. 6A) . Moreover, the amount of lactate released was then monitored at regular intervals over a period of 10 h (Fig. 6B) . Lactate was rapidly secreted from cells in a time-dependent manner after 2 h and the release was clearly higher in basal-like cells than in luminal-like cells. In particular, lactate level was at least twice as high in MDA-MB-231 cells at each time point, revealing that this cell line had the greater glycolytic potential than MCF-7.
Given that we found a functional metabolic shift to more lactate production in the basal-like cell line, we sought to identify differences in expression of the main regulators of lactate balance and metabolism: lactate dehydrogenase (LDH) and monocarboxylate transporters (MCT). The LDH isozymes that play a role in lactate metabolism are LDHA and LDHB. LDHA is mainly associated with pyruvate to lactate conversion, and LDHB with lactate to pyruvate conversion. MCT1 and MCT4 have been reported to play a role in cancer cells. MCT1, which has a high affinity for lactate, brings lactate into the cell, whereas MCT4, which has a low affinity for lactate, brings lactate outside the cell [30] . Therefore, we assayed the expression levels of the LDH (A and B) and MCT (1 and 4) isoforms in the MCF-7 and MDA-MB-231 breast cancer cell lines (Fig. 6C,D) . Western blot analysis showed that the basal-like cell line expressed the higher protein level of LDH isoforms compared to the luminal-like cells. In particular, LDHB was not even detectable in Oxidative damage was evaluated by measuring lipid peroxide and protein carbonyl levels in whole cell lysates using spectrophotometric assay and immunoblot detection, respectively. Histogram of protein carbonyls levels represents quantification of oxyblot data expressed as a ratio of oxyblot band average intensity to actin band intensity. (E) Antioxidant enzyme activity (peroxidase, catalase and SOD) was measured in whole cell lysates by spectrophotometric assays. Activities measured for MCF-7 cells were set at 100%. For all the experiments above, results are expressed as mean AE SD from at least three independent experiments. Asterisks indicate values that are significantly different from those obtained in MCF-7 cells; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, as indicated by ANOVA (panels A and B) or Student's t test (panels C and D).
the MCF-7 cells. Moreover, the expression of MCT1 was higher in luminal-like cancer cells than in metastatic ones, whereas MCT4 was expressed in MDA-MB-231 cells but not in MCF-7 cells (Fig. 6C) ; these findings are consistent with the literature [30] . The data suggest that the LDH and MCT isoforms have 
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The FEBS Journal 286 (2019) 688-709 ª 2019 Federation of European Biochemical Societies distinct expression patterns in the two breast cancer cell lines and that these differences could contribute to differing lactate dynamics and oxidative capacities in these cells. Changes in the expression of lactate shuttle proteins and enzymes involved in lactate metabolism seem to be associated with alterations in oxidative capacity and lactate accumulation within breast cancer cells.
To determine whether cancer cells have a diversity of energy production pathways, predominantly oxidative or glycolytic, we evaluated the ratio of mitochondrial ATP over glycolytic ATP in the two cell lines tested. The results showed a greater than threefold reduction in the basal-like MDA-MB-231 cell line compared to the MCF-7 cell line (Fig. 6E) . This suggests, once again, a higher glycolytic flux in triplenegative cells.
Moreover, in order to verify if bioenergetic differences observed between the MCF-7 and MDA-MB-231 cells equated to differences in energy provision, we measured ATP using an ATP-based luminescent assay. Experiments were carried out in Dulbecco's modified Eagle's medium (DMEM) containing 25 mM glucose (high glucose), which is significantly higher than the normal physiological conditions of 4-8 mM, and in DMEM containing 5.5 mm glucose (low glucose), which approximates normal serum glucose levels in vivo. All cell cultures were initially maintained in high-glucose medium and plated onto six-well plates for 1 day; on the following day the media were replaced with fresh medium containing either 25 or 5.5 mM glucose. As shown in Fig. 6F , there was no significant difference in the cellular ATP level between the luminal-and the basal-like cells cultured in highglucose medium. In contrast, a significant reduction (~40%) in ATP level was observed in MDA-MB-231 cells cultured in low glucose medium. While high-glucose medium creates an optimal environment for cancer cell proliferation, the constant availability of glucose could provide a less accurate view of cellular metabolic status, masking potential differences in ATP production efficiency between the two cancer cell lines. It was possible to dynamically monitor the effect of OXPHOS and glycolysis inhibitors to obtain an accurate measurement of the contribution of glycolysis and oxidative phosphorylation to the intracellular ATP production. To mimic OXPHOS suppression, we used oligomycin, a potent inhibitor of mitochondrial ATP synthase, whereas to inhibit ATP production through the glycolytic pathway, 2-deoxyglucose (2-DG), a nonmetabolizable glucose analog, was used. Specifically, 2-DG inhibits glycolysis through hexokinase phosphorylation and is converted to a nonmetabolizable, 2-DG-6-phosphate [31] . After incubation for 24 h in medium containing high or low glucose, the cells were treated with either 25 mM 2-DG or 1.5 lgÁmL À1 oligomycin for 6 h. Treatment at the indicated concentration and time period did not affect survival of the two cell lines grown both in 25 and 5 mM glucose, as measured by trypan blue vital staining (data not shown). In highglucose medium, total intracellular ATP was not altered by treatment, except for a slight but insignificant reduction in ATP level in the MDA-MB-231 cells treated with 2-DG (Fig. 6F) . On the other hand, in low-glucose medium the inhibition of glycolysis dramatically lowered (> 75%) steady-state ATP levels in MDA-MB-231 cells, while only moderately inhibiting ATP production in MCF-7 cells (~30%), suggesting that glycolysis contributes more to the maintenance of ATP production in phenotypically aggressive breast cancer cells than in luminal-like subtype cancer cells. The inhibition of mitochondrial ATP production by oligomycin produced a significant effect in MCF-7 cells grown in low-glucose medium reducing ATP content by about 50%; this finding suggests that the upregulation of mitochondrial function might be sufficient to compensate for the decreased ATP generation by glycolysis. On the contrary, under treatment with oligomycin MDA-MB-231 cells underwent a very limited effect, maybe due to the low dependence of this cell line on mitochondrial respiration for ATP production. Consistent with these results, such as the higher glycolytic rate, and the increased release of lactate, MDA-MB-231 cells also exhibited a higher NADH/ NAD + ratio than MCF-7 cells (Fig. 6G) , likely due to less oxidation of NADH to NAD + by the compromised complex I activity and more conversion of NAD + to NADH during active glycolysis.
Mitochondrial OXPHOS defects in EMT models
To further investigate the association between mitochondrial alterations and EMT, we compared the mitochondrial respiratory efficiency of two other types of cancer cell lines with a different expression of epithelial and mesenchymal markers, T47D and MDA-MB-435 (Fig. 7A) . First, we evaluated their mitochondrial respiratory efficiency by measuring oxygen consumption (Table 2 ). T47D cells showed no significant differences in V 3 , V 4 , and RCR values compared to MCF-7 cells, whereas MDA-MB-435 cells exhibited a significant decrease in mitochondrial respiration comparable to that found in MDA-MB-231 cells (see also Fig. 7B,C) . Interestingly, MDA-MB-435 cells exhibited very low rotenone-sensitive respiration (Fig. 7C) , confirming the presence of a defective mitochondrial complex I. Overall, these data ( Table 2 and Fig. 7 ) further strengthen the association between EMT and mitochondrial defects, but partly account for the role that specific markers may play in this metabolic reprogramming. Given the critical role of E-cadherin and b-catenin in EMT initiation, we investigated the mitochondrial functional changes associated with the knockdown of these two EMT markers, excluding in this way any possible effects due to the presence of mitochondrial complex genetic alterations. Lentiviral small hairpin RNA (shRNA)-mediated knockdown of E-cadherin (MCF-7 shEcad) and b-catenin (MCF-7 shbcat) (Fig. 7E ) caused a significant decrease in mitochondrial respiration compared to MCF-7 control cells (scramble) ( Table 2 and Fig. 7D ). These findings imply that OXPHOS modifications are part of the metabolic reprogramming that occurs during EMT. Moreover, cells knocked down for E-cadherin and b-catenin modulate their energetic status in favor of lactate production.
As shown in Fig. 7F , we measured the extracellular lactate release in both clones and compared these results with those obtained using epithelial and mesenchymal models. T47D cells showed a pattern of lactate release similar to that of MCF-7, whereas MDA-MB-435, such as MDA-MB-231 cells, showed a significant increase of the extracellular lactate levels in comparison to luminal-like subtype cell lines. Interestingly, E-cadherin or b-catenin knockdown led to an increase of lactate production and secretion compared to MCF-7 cells, showing an intermediate profile between luminal-and basal-like subtype cells. Taken all together, these results suggest that downregulation of EMT markers could be responsible for a decrease in mitochondrial respiration efficiency, with a subsequent impact on cellular metabolism.
Discussion
EMT is the process that allows cells to change their morphology, by a morphological switch from the epithelial polarized phenotype to the mesenchymal fibroblastoid phenotype. In recent years, several studies have been aimed at understanding the contribution of EMT to tumor invasion, migration, and metastatic outgrowth in various types of cancer. However, metabolic reprogramming and, in particular, changes in mitochondrial function during EMT are largely unknown. In view of the important role EMT plays in breast cancer metastasis and chemoresistance, we sought to better define the metabolic differences underlying EMT as these may exert a strong influence on the process. In this study, we determined the existence of a distinct metabolic phenotype associated with EMT by using two breast cancer models with different metastatic potentials, MCF-7 (an epithelial luminallike breast cell line) and MDA-MB-231 (a mesenchymal basal-like breast cell line).
The biochemical and functional studies reported herein reveal that the basal-like cell line exhibits a significant decrease in mitochondrial respiration and a particularly marked uncoupling between electron transport activity and phosphorylation in mitochondria compared to luminal-like cells, demonstrating that OXPHOS deficiency is strictly correlated with the (2, 4, 6, 8 , and 10 h), culture medium was collected for enzymatic lactate measurements. Lactate production was normalized to total protein concentration. Data are presented as mean AE SD from three independent experiments (**P < 0.01, ***P < 0.001 vs MCF-7 cells, using ANOVA).
metastatic and invasive properties of tumor cells. This finding is supported by western blot analysis showing the downregulation in MDA-MB-231 cells of SDHB, the core catalytic subunit of the mitochondrial heterotetrameric complex of SDH, involved in both the citric acid cycle and electron transport chain. Indeed, several studies have found that decreased SDHB expression results in reprogrammed carbon source utilization and mitochondrial dysfunction. This altered metabolic state promotes cell migration and invasion by enabling EMT [32] [33] [34] . Moreover, we found a lower expression of the complex I NDUFB8 subunit in MDA-MB-231 cells compared to MCF-7 cells. NDUFB8 is not involved in the catalytic action of complex I, but is an essential component of the nDNA encoded membrane anchor required for the full assembly of the holoenzyme and for supercomplex assembly with complex III [35] . The impaired assembly of complex I often results in its dysfunction [36] , as appears evident in the basal-like cell line. Moreover, complex I deficiency seems to be compensated by an increase in complex IV activity, as already observed in other cell lines [37] ). Therefore, the lower respiratory rate in MDA-MB-231 cells could be associated with the strong decrease in complex I activity suggesting its specific role in tumor growth. A previous study has demonstrated that mitochondrial complex I can control breast cancer progression by regulating the balance of cellular NADH/NAD + [38] . We found that MDA-MB-231 cells also exhibited a higher NADH/ NAD + ratio than MCF-7 cells, likely due to less oxidation of NADH to NAD + by the impaired complex I activity and more conversion of NAD + to NADH during active glycolysis. High NADH levels lead to inhibition of the pyruvate dehydrogenase complex, which is involved in the oxidation of pyruvate derived from glycolysis into acetyl-CoA [39] . This event causes an increase in glycolytic pyruvate levels with a consequent truncation of the tricarboxylic acid cycle (TCA) and an upregulation of lactic fermentation. Under normoxic conditions, glucose is metabolized in the cytosol to pyruvate, which enters the TCA cycle; reducing equivalents (NADH and FADH 2 ) are generated to feed OXPHOS activity for ATP production. Instead, when O 2 tension is low and OXPHOS slows down, pyruvate is mainly converted by LDHA into lactate through lactic fermentation, which upon NADH oxidation restores the NAD + pool needed to drive glycolysis [40] . Therefore, lactate cannot be considered a mere waste product of glycolysis, but rather an important player in tumor energetic metabolism.
The higher lactate production observed in MDA-MB-231 cells compared to MCF-7 cells was accompanied by the differential expression of LDH isoforms in the two cell lines. In particular, LDHA, which is mainly associated with pyruvate to lactate conversion, is overexpressed in the basal-like cells, whereas LDHB, which mainly catalyzes the conversion of lactate into Table 1 . V 3 was the rate of oxygen uptake recorded in the presence of added substrates + ADP; V 4 was the rate of oxygen uptake observed when added ADP had been completely phosphorylated to ATP; RCR vas calculated dividing V 3 by V 4 . *P < 0.05, **P < 0.01, ***P < 0.001 vs MCF-7 cells.
pyruvate, is undetectable in the luminal-like cells. LDHA is upregulated in many cancers including breast cancer and is shown to be important in tumor initiation and progression [41, 42] . In contrast, LDHB expression is absent in some prostate and breast cancer types [43, 44] and is correlated with a poor clinical outcome [45] . In addition to LDH isoforms, the main MCTs -MCT1 and MCT4 -are also differentially expressed in luminal-and basal-like breast cancer cells. MCT4 has a high affinity for lactate, thus facilitating lactate release to the extracellular matrix. In contrast, MCT1 has a high affinity for both lactate and pyruvate and may be more important for lactate uptake in oxidative cancer cells. In this context, we found that MCT1 is highly expressed in luminal-like cells compared to basal-like cells, whereas MCT4 is expressed in basallike cells but not in luminal-like cells; these findings are consistent with the literature [30] . Previous studies and our findings show that elevated expression of MCT4 is a hallmark feature of triple-negative breast cancer and correlated with a poor clinical outcome [46] . The biochemical feature of MCT4 is very important for acquisition of the metastatic phenotype and is associated with a series of metabolic adaptations of cancer cells. Indeed, imported lactate released in the tumor microenvironment is actively taken up and utilized by well-oxygenated cancer cells to produce ATP through OXPHOS. This metabolic coupling may be advantageous for the cancer cell population, since oxygenated cancer cells use lactate preferentially, reserving glucose for cancer cells that are not able to undergo aerobic respiration. Additionally, microenvironment lactate benefits the cancer cells by inducing oxidative stress in surrounding stromal nontransformed fibroblast, which leads to the destruction of their mitochondria by autophagy. This results in stromal cells with a reduced number of functional mitochondria; these cells must undergo a switch to glycolysis to meet their bioenergetic needs that is reverse Warburg effect. The ability of cancer cells to modulate the metabolism of neighboring stromal cells helps to support their growth in the stringent tumor microenvironment. Overall, lactate acts not only as a cancer cell metabolic fuel but also as a signaling mediator in cancer and endothelial cells promoting inflammation, angiogenesis, immunosuppression, and radioresistance. In this context, MCT4 plays an important role in this symbiotic strategy used by cancer cells [47, 48] .
In summary, these findings highlight the connection between MCT subtype expression and lactate consumption by cancer cells. Given the differences in expression of the MCT and LDH isoforms, it could be hypothesized that lactate uptake and catabolism are different between the two breast cancer cell lines: MCF-7 cells are high lactate consumers and exclusively express the LDHA isoform and high MCT1 levels, whereas MDA-MB-231 cells are low lactate consumers and express high MCT4 and LDHB levels, probably utilizing more glucose concomitantly. Accordingly, this model shows a high dependence on glycolytic ATP rather than oxidative ATP. Indeed, our results indicate that glycolysis contributes to ATP production in MCF-7 cells, but accounts for most, if not all, of the ATP produced in MDA-MB-231 cells. On the other hand, MCF-7 cells are more dependent on mitochondrial respiration, which makes them very sensitive to inhibitors of mitochondrial function.
In the context of energy production, the mitochondrial ANTs have been suggested to play an important role in regulating energy homeostasis and, thus, may become key players in the regulation of metabolic adaptation of neoplastic cells. Under normal physiological conditions, ANTs exchange cytosolic ADP for matrix ATP or cytosolic ATP for matrix ADP through the inner mitochondrial membrane. The transport direction is driven by the membrane potential (DΨ m ) generated by OXPHOS. Both ANT1 and ANT3 export ATP produced by OXPHOS from the mitochondrial matrix to the cytosol. ANT2 has kinetic properties, which are different from those of the other two isoforms and catalyzes the uptake of glycolytic cytoplasmic ATP in exchange for intramitochondrial ADP [49] .
Given their essential role in cellular energy metabolism, the expression of ANT isoforms is closely related to the energetic metabolic properties of tumor cells [49] . Interestingly, we found significant changes in the gene expression and the protein levels of ANT isoforms in the two breast cancer cell lines. In particular, ANT1 is higher in MDA-MB-231 cells, whereas ANT2 and ANT3 are more highly expressed in MCF-7 cells. Some tumor cell lines, as MCF-7 cells, maintain the ability to use their mitochondrial energetic background through the induction of ANT2 expression, which promotes the switch from mitochondrial OXPHOS activity to a prevalently glycolytic metabolism. This provides an advantage in terms of proliferation because of the availability of intermediates including lactate for active cell anabolism. ANT2 is thus likely to have kinetic parameters that favor glycolytic ATP uptake into mitochondria (required for the maintenance of the mitochondrial membrane potential) and specific intramitochondrial anabolic pathways (essential for cell growth). The ADP produced would then exit mitochondria from ANT2 and be rephosphorylated by glycolysis.
As confirmed by this study, the ANT2 and ANT3 genes are coexpressed in tumor cells. While the ANT3 gene is expressed in all cells and tissues, ANT2 expression is particularly upregulated in transformed cells [49] . On the contrary, since in basal-like MDA-MB-231 cells mitochondria are markedly uncoupled and functionally compromised compare to luminal-like MCF-7 cells, we can speculate that MDA-MB-231 cells are unable to sustain oxidative metabolism and that ANT2 expression seems to be unnecessary to switch to glycolysis.
Therefore, the overexpression of ANT1 could play a cell-protective effect under hypoxic conditions, as already observed in hypoxic cardiomyocytes [50] . This effect could be related to the stabilization of the mitochondrial membrane potential and to the activation of the cell-protective signaling events involved in cell survival and in the glycolytic pathway. However, an overexpression of ANT1 has not been observed in [51] where the authors suggested that ANT1 transfection induced mitochondrial membrane potential disruption and consequently apoptosis in MDA-MB-231 cells. These different results could be due to the different experimental approach (an inducted overexpression) used in this study. On the basis of our evidence, we could propose ANT1 as an emergent player in tumorigenesis and poor cancer prognosis, in addition to the known role of ANT2 as a key mitochondrial protein in cancer metabolism [49] .
ADP/ATP translocases are functional components of mitochondrial ATP synthasome, which also includes PiC and ATP synthase [52] . ATP synthase, or complex V, uses the energy created by the proton electrochemical gradient to phosphorylate ADP to produce ATP. It is well established that ATP synthase can function in reverse as an ATP hydrolase for maintaining the proton motive force and for sustaining metabolic demand. This process is regulated by ATPIF1, which plays a role in the control of cellular energetic metabolism participating as an additional molecular switch to aerobic glycolysis [53] . Although the inhibitor has being deeply investigated, its role in tumorigenesis and/or cancer progression is still debated. Some authors report that ATPIF1 overexpression is related to the acquisition of several cancer phenotype hallmarks, including metabolic reprogramming, increased proliferation and invasion, and cell evasion from death [54] . Conversely, other studies demonstrate that the high expression level of ATPIF1 in breast carcinomas yields a biomarker of good prognosis for the patients because of the poorer potential of the cells to migrate and invade due to a better maintenance of the extracellular matrix and epithelial phenotype [55] .
Recently, it has been proposed that ATPIF1 expression level affects mitochondrial ultrastructure altering the shape and organization of cristae membranes, by a modulation of the rate of ATP synthase dimerization [56] . Increased levels of ATPIF1 improve the stability of mitochondrial membranes, limiting both apoptotic mitochondrial remodeling and permeabilization. Moreover, the enzymatic efficiency of ATP synthase is preserved, hindering ROS production and ATP loss. Accordingly, reduced ATPIF1 activity has also been correlated with higher ROS levels [57, 58] .
Reactive oxygen species are generated by complex mechanisms of which the most relevant is the incomplete oxidative phosphorylation that occurs during biomolecule catabolism, especially in the electronic transport chain. However, ROS are not mere by-products of respiration; evidence indicates that they play an important role as signaling molecules in many physiological processes to mediate various biological responses, such as gene expression, cell proliferation, angiogenesis, innate immunity, apoptosis, and senescence. On the other hand, elevated levels of ROS can exert harmful effects by causing oxidative damage to biological macromolecules, such as intracellular lipids, proteins, and DNA, and disrupting the cellular reduction-oxidation (redox) balance [59] . It has long been postulated that ROS can promote many aspects of tumor development and progression [60] . Additionally, ROS can induce metabolic reprogramming of cancer cells and surrounding stroma, facilitating tumor growth [61] ; they are also able to act directly on EMTassociated pathways, driving the cancer phenotype [62] . Indeed, ROS accumulation may lead to increased cell mobility, diminished cell-cell conjunctions, cytoskeleton remodeling, downregulation of epithelial cell markers, upregulation of mesenchymal markers, and degradation of the extracellular matrix [63] . In agreement with this hypothesis, we demonstrated that the basal-like cell line MDA-MB-231 produces larger amounts of both extracellular and intracellular ROS compared to the MCF-7 cell lines. This may be due in part to the severe impairment of mitochondrial complex I, which is the major site of ROS production in the mitochondrial electron transport chain [64] . The impairment of complex I activity leads to a bottleneck in the complex during electron transfer, and electron leakage could ensue which leads to further ROS production. Overall, this could influence the metabolic phenotype of MDA-MB-231, as these cells are forced to adopt strategies to maintain stable levels of ROS and because ROS are important cellular secondary messengers. However, none differences in ROS production between MCF-7 and MDA-MB-231 cells in basal condition have been observed in [65] . These apparent contrasting results could be due to the different experimental times used for the evaluation of H 2 O 2 extracellular release levels.
Redox homeostasis disturbances in tumor cells are associated with increased ROS production as well as with aberrant antioxidant systems of which the main detoxifying enzymes are three SOD isoforms (citosolic Cu/ZnSOD or SOD1, mitochondrial MnSOD or SOD2, and extracellular SOD or SOD3), catalase, and different types of peroxidases. These enzymes are often reported to be modified in cancer and have been linked to carcinogenesis [66] .
Because mitochondria are the major producers and main targets of ROS, massive accumulation of reactive chemical species leads to elevated expression of SOD2 to inhibit oxidative damage in mitochondria [67] . In addition to its well-known role as antioxidant, SOD2 overexpression adversely affects mitochondrial functions and cellular energy metabolism. In particular, high levels of SOD2 strongly inhibit mitochondrial oxidative metabolism and greatly stimulates glycolysis through H 2 O 2 production and activation of specific signaling pathways [68] . Therefore, SOD2 could contribute to the progression of cancer by promoting aggressive phenotypes during EMT. Indeed, our results have revealed an upregulation of SOD2 in the more invasive breast cancer cell line MDA-MB-231 compared to the luminal-like cell line MCF-7. Interestingly, this was confirmed in a larger panel of tumor luminal and basal-like models as well as in tumor samples of basal-like breast cancers subtypes compared to luminal-like breast cancer subtypes, as shown in Fig. 5 . For the first time, we highlight the role of SOD2 in triple-negative physiology and candidate the protein to a further functional validation screening.
The results of this study, even if preliminary, suggest that luminal-and basal-like breast cancer cells display a distinct bioenergetic and metabolic phenotype and, consequently, exhibit altered dependency on specific metabolic pathways (Fig. 8) . Moreover, we can speculate that these bioenergetic phenotypes are the results of the metabolic rewiring occurring during EMT. Consistently, the downregulation of the EMT markers, such as E-cadherin and b-catenin, induces a significant decrease in mitochondrial respiration and enhances lactate production. Our data collectively support the association between EMT and mitochondrial dysfunctions. The presence of complex I protein alterations observed in mesenchymal models as well as the activation of specific signaling networks that may be activated after the knockdown of EMT markers can both have a role in determining mitochondrial dysfunction and, importantly, in cellular metabolism.
Mitochondrion is the metabolic hub of the cell that not only is responsible for energy production, but also catabolizes nutrients, such as glucose, amino acids, and fatty acids, to produce building blocks for cell growth. Thus, the severe mitochondrial dysfunction observed in basal-like breast cancer cells and the resulting alterations in redox balance impact on the regulation and function of cellular metabolism, forcing the cells to adapt and rewire their metabolic status to meet the needs of rapid proliferation. Here, we demonstrated that the impairment of NADH oxidation induces a cellular metabolic shift toward anaerobic glycolysis, but other pathways involving metabolic flux through circuitries centered on mitochondria may be affected. For example, the downregulation of TCA cycle and the concomitant suppression of the mitochondrial oxidation of pyruvate into acetyl-CoA by pyruvate dehydrogenase (as a consequence of the upregulated reduction of pyruvate into lactate in the cytosol by LDH) force the cells to acquire acetyl-CoA from different sources including acetate. This results in a glucose-to-acetate metabolic switch to provide acetyl-CoA for de novo lipogenesis or for acetylation reactions, which regulate transcription as well as cytoplasmic processes [69] .
Marked alteration of mitochondrial functionality affecting basal-like cancer cells has been proved to be essential for driving their metabolic plasticity. It is possible to speculate that these cells use different fuel sources for their metabolic needs and have even developed specific mechanisms to obtain metabolic substrates from extracellular and intracellular sources. These metabolic adaptation mechanisms can create 'bottlenecks' whereby cancer cells rely on particular pathways or rate-limiting substrates.
In this context, a better understanding of these critical adaptations, which render cancer cells dependent on distinctive metabolic pathways, is clearly needed. These studies could gear the establishment of new therapeutic strategies using energy metabolism as target and based on the combination of pharmacological and nutritional interventions.
Materials and methods
Cell culture
Human tumor cells were purchased from the American Type Culture Collection (ATCC) or from Banca Biologica and Cell Factory (IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la ricerca sul cancro, Genova, Italy). Human cancer cell lines MCF-7, MDA-MB-231, T47D, and MDA-MB-435 were cultured in DMEM medium (EuroClone, Milan, Italy) supplemented with 10% FBS (EuroClone), 100 UÁmL À1 penicillin, and 100 lgÁmL À1 streptomycin at 37°C in an atmosphere of 5% CO 2 . MCF-7 cells with stable knockdown of endogenous b-catenin or E-cadherin were obtained as previously described [69, 70] .
Mitochondrial functionality assays
Oxygen uptake by digitonin-permeabilized cells (1 9 10 6 cells) or highly pure mitochondria (100 lg) obtained as described in Ref. [71] was measured by using a Clark-type oxygen probe (Hansatech Instruments Ltd, Kings Lynn, Norfolk, UK) [72] . The addition of different substrates permitted to evaluate mitochondrial respiration when respiratory complexes I (10 mM pyruvate, 10 mM malate), II (10 mM succinate, 3 lM rotenone), or IV (10 mM ascorbate, 0.2 mM N,N,N 0 ,N 0 -tetramethyl-p-phenylenediamine or TMPD, 3 lM rotenone, 2 lM antimycin A) were stimulated. For each substrate, after 2 min, state 3 respiration was induced by the addition of 0.5 mM ADP. RCR was calculated as the ratio of the rate of oxygen uptake in the presence of added ADP (state 3 or V 3 ) to the rate observed when added ADP had been completely phosphorylated to ATP (state 4 or V 4 ) [73] .
Mitochondrial respiratory complexes activities were evaluated spectrophotometrically, essentially as described in Ref. [74] .
The mitochondria membrane potential (DΨ m ) was evaluated in intact cells by using the cationic dye JC-1 (Molecular Probes, Inc., Eugene, OR, USA), which exhibits potential-dependent accumulation in mitochondria [75] .
Determination of mtDNA copy number
Total DNA from cells was obtained by phenol/chloroform extraction and processed as previously described [69] . Quantitative real-time PCR was performed to quantify mtDNA content. Primers used for Dloop and Gapdh, mitochondrial and nuclear specific DNA sequences, respectively, are reported in Table S2 . mtDNA level was expressed as the ratio of mtDNA to nuclear DNA quantity (mtDNA/nDNA).
RNA extraction and real-time PCR
Total RNA was extracted from cells using the Direct-zol TM RNA MiniPrep kit (ZYMO RESEARCH, Irvine, CA, USA) according to the manufacturer's protocol. Real-time PCR experiments were performed as described previously [69] . Primers and relative concentration used were reported in Table S2 . Rplp0 gene was used as a reference gene. All assays were performed in triplicate and data are represented as mean AE standard deviation (SD).
Western blot
Whole proteins were extracted in radioimmunoprecipitation assay (RIPA) buffer (Cell Signaling Technology, Inc., Leiden, the Netherlands) and quantified by the Bradford protein assay (Bio-Rad, Hercules, CA, USA). Samples were separated by 10% sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS/PAGE) and transferred to nitrocellulose membranes (GE Healthcare Life Sciences, Marlborough, MA, USA) [76] . Membranes were blocked for 1 h in Tris-buffered saline (TBS), 0.1% Tween-20, 5% nonfat dry milk, and incubated with the appropriate primary antibodies (see Table S1 ) for 2 h at room temperature as described [70] . Densitometric analysis of at least three independent replicates was performed using IMAGEJ software (National Institutes of Health, Bethesda, MD, USA).
Measurement of oxidative damage
Intracellular H 2 O 2 levels and H 2 O 2 released from breast cancer cell lines were measured by using the Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (Molecular Probes, Inc.), according to the manufacturer's instructions.
Protein carbonyl and lipoperoxide content is widely used as a marker for oxidative stress and a measure of oxidative damage. Carbonylated proteins and lipoperoxides were detected by using the OxyBlot TM Protein Oxidation Detection Kit (Merck Millipore, Billerica, MA, USA) [77] and the PeroxiDetect TM kit (Sigma-Aldrich, St. Louis, MO, USA), respectively, according to manufacturer's instructions. Lipids were isolated using the Bligh and Dyer method [78] .
Antioxidant enzyme activities
Peroxidase activity was determined by using the Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (Molecular Probes, Inc.), whereas the superoxide dismutase (SOD) activity was measured using the Cayman Chemical SOD assay kit (Cayman Chemical, Co., Ann Arbor, MI, USA), according to the manufacturer's instructions. The SOD assay measured both the cytosolic (Cu/ZnSOD or SOD1) and mitochondrial (MnSOD or SOD2) activity of the enzyme. MnSOD activity was determined by performing the assay in the presence of potassium cyanide to inhibit Cu/ZnSOD and thus measuring the residual MnSOD activity.
Catalase activity was assayed by the method of Luck [79] .
Lactate production
Lactate production measurement was carried out following the method described by Merlo-Pich et al. [80] with some modifications [81] . From the lactate data, it was possible to calculate basal lactate as glycolytic ATP (in the absence of oligomycin, inhibitor of mitochondrial respiration), D-lactate (the difference of lactate production in the presence and absence of oligomycin) as mitochondrial ATP, and the ratio D-lactate/basal lactate as the ratio of mitochondrial ATP and glycolytic ATP [80] .
Cellular ATP content
Intracellular ATP concentration was measured by the ATP Bioluminescent Assay Kit (Sigma-Aldrich) according to the manufacturer's instruction. In brief, cells were plated into a six-well plate at a density of 2 9 10 5 per well and incubated for 24 h in medium containing 25 mM (high glucose) or 5.5 mM (low glucose). After seeding overnight, the cells were treated with either 25 mM 2-DG or 1.5 lgÁmL
À1
oligomycin for 6 h to measure either oxidative ATP content or glycolytic ATP production, respectively [82] . Results were normalized to the total protein level in cell lysate, as determined by the Bradford method.
NADH/NAD + analysis NAD + and NADH levels were measured using a NAD + / NADH quantitation kit (Sigma-Aldrich). Briefly, 2 9 10 5 MDA-MB-231 or MCF-7 cells were lysed according to manufacturer's instructions. Data were normalized to total protein content determined using the Bradford protein assay.
Statistics
All data were analyzed using the statistical software GRAPH-PAD PRISM (5.0 version, GraphPad Software, La Jolla, CA, USA). Pairwise comparisons between means of different groups were performed using a Student's t-test (two tailed, unpaired). Multiple comparisons were performed using a univariate ANOVA. Values at P ≤ 0.05 were considered statistically significant, while values at P ≤ 0.01 and P < 0.001 were considered very significant.
Analysis of breast cancer microarray data sets
RNA-sequencing and microarray data were downloaded from Gene Expression Omnibus (GEO) under access codes GSE100878 [28] and GSE41313 [29] , respectively. The microarray data (Human Genome U133A Array, 215223_s_at) from breast invasive carcinoma were downloaded from the ONCOMINE platform (https://www.onc omine.org/resource/main.html) [83] .
The mRNA expression level of the SOD2 gene, specifically in breast cancer, was analyzed using the GOBO database (http://co.bmc.lu.se/gobo). Analyses were performed by GOBO in an 1881-sample breast tumor data set generated on Affymetrix U133A microarrays [84] .
Supporting information
Additional supporting information may be found online in the Supporting Information section at the end of the article. Table S1 . List of antibodies used in western blotting. Table S2 . Oligonucleotides used for real-time PCR analysis.
